Skip to content

Anxiety relief and mild activation

The clinical report earns attention for a pairing that sounds less simple than the word calming.

The reported clinical effects

A Russian clinical study of intranasal Selank described anxiety reduction in patients with generalized anxiety disorder, comparable to a benzodiazepine comparator, alongside mild activating effects. The report also described an absence of sedation, cognitive impairment and withdrawal in that study.

Mild activation is the phrase I underline. It gives the reported effect a little movement. For my purposes, calm has room for someone remaining engaged with the world; the combination sounds richer than a picture of everything simply becoming still. Appealing is an opinion about the question; the clinical finding remains attached to the patients in this report.

The pairing deserves serious consideration within the clinical setting described. A comparison in generalized anxiety disorder has a defined clinical setting. Moving from that setting to ordinary worry, a demanding afternoon or a desire for sharper concentration would require additional evidence. The attraction of the description makes that boundary especially easy to overlook.

Tolerability in the report

The reported absence of sedation, cognitive impairment and withdrawal is relevant to the kind of calm I’m interested in. It still needs the scope of the report around it. An outcome described in these patients cannot establish how every other person would respond, or settle a question about prolonged use simply by sounding reassuring.

Relief and participation deserve a comparison together: how anxiety changes, how alert people remain, and what unwanted effects occur. I would also value replication that tests the same clinical claim directly. I’m asking for an experiment that tests that preference, with room for an unwelcome answer.

The rat brain findings and the plasma experiment make this a richer subject, but they do not add more patients to the clinical report. After all that molecular bustle, the human question is still wonderfully concrete: what changed for the people who were studied? That concrete question gives this paper its value to me.